Five novel triterpenoid saponins from Hovenia dulcis and their Nrf2 inhibitory activities

This study suggested that the active triterpenoid saponins from Hovenia genus may serve as privileged constituents in future anti-tumor drug discovery.

Please go to: https://www.sciencedirect.com/science/article/pii/S1878535221003075